Invest and Sell RefleXion Medical Stock

Q: How to sell RefleXion Medical stock?

If you hold private company shares of RefleXion Medical - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your RefleXion Medical stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Enterprise Value

Access RefleXion Medical’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like RefleXion Medical.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Samuel Mazin Ph.D

Co-Founder & Chief Technology Officer

Todd Powell

President & Chief Executive Officer

Martyn Webster

Chief Financial Officer

Thorsten Melcher Ph.D

Chief Business Officer

Shervin Shirvani MD

Chief Medical Officer

Board Members

Antoine Papiernik

Sofinnova Partners

Nael Kassar

KCK Group

RefleXion Medical stock FAQs

Can you buy RefleXion Medical stock?

As RefleXion Medical is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like RefleXion Medical, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy RefleXion Medical stock?

To invest in a private company like RefleXion Medical through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell RefleXion Medical stock?

Yes, you may be able to sell your RefleXion Medical stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell RefleXion Medical stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your RefleXion Medical stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is RefleXion Medical a public company?

No, RefleXion Medical is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is RefleXion Medical’s stock price?

RefleXion Medical is a privately held company and therefore does not have a public stock price. However, you may access RefleXion Medical’s private market stock price with Forge Data.

What is RefleXion Medical’s stock ticker symbol?

RefleXion Medical does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

YahooFiance 09/28/2023

RefleXion Showcases Breakthrough SCINTIX Biology-Guided Radiotherapy and Highlights New Research at ASTRO 2023 Meeting

RefleXion® Medical, a therapeutic oncology company, today announced the company will showcase the RefleXion® X1 with SCINTIX™ biology-guided radiotherapy at the American Society for Radiation Oncology (ASTRO) Annual Meeting, Oct. 1-4, 2023 in San Diego (booth #2831). Researchers from multiple clinical programs will present new scientific evidence in 20 presentations, including two oral presentations, supporting the potential of SCINTIX therapy, which is delivered only through the X1 platform.

AuntMinnie 09/21/2023

RefleXion acquires radiopharmaceutical rights from 3B Pharmaceuticals

RefleXion Medical has acquired the exclusive rights to develop and commercialize a specific molecule, RXM-4768, from 3B Pharmaceuticals. This molecule targets fibroblast activation proteins found in nearly all solid tumor types and could expand the patient population eligible for Scintix therapy. The deal includes upfront and annual license payments to 3B Pharmaceuticals, with additional payments upon certain milestones.

Mass Device 08/23/2023

First cancer patient treated with RefleXion biology-guided radiotherapy

RefleXion Medical has announced the first patient has completed treatment using its Scintix biology-guided radiotherapy on its X1 machine. The treatment uses the individual biology of each tumor to determine the amount of radiation required, receiving FDA clearance in February of this year. The company expects to offer the treatment in specific cancer centers in California, Pennsylvania, and Texas soon, with New Jersey, Connecticut, and Oregon to follow by the end of 2023.

Medical Device Network 02/09/2023

RefleXion’s Scintix Biology-Guided Radiotherapy, USA

RefleXion Medical has developed an innovative biology-guided radiotherapy, Scintix, which uses cancer's unique biology for controlled radiotherapy delivery. The treatment received FDA clearance in February 2023 and is indicated for lung and bone cancers. The Scintix technology can detect and treat various moving cancers without affecting healthy tissues. This development represents a significant advancement in the field of oncology.

RefleXion Medical Stock

Register To Buy and Sell Shares